Our Mission

To transform the lives of patients with unmet medical needs by bringing best-in-class immune-based therapies to patients in need.

Our Pipeline

Rapidly advancing a deep portfolio of innovative therapeutics that continues to expand through our successful business development strategy.

Latest News

November 21, 2021

Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor

May 3, 2021

Zenas BioPharma Announces New Executive Leadership Appointments

long-arrow-right-regularfacebook-brandsfacebook-f-brandsinstagram-brandslinkedin-brandslinkedin-in-brandssubmit-arrowtwitter-brandstwitter-square-brandsyoutube-brands